Brind.

Danaher Corporation and AstraZeneca formed a partnership to scale precision medicine.

1 report, 1 independent Updated Jul 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Danaher Corporation AstraZeneca

Keep exploring

The entities involved

Danaher Corporation
American conglomerate
- Sidharth Kapileshwar joins MaxCyte as Chief Corporate Development Officer after leaving Danaher Corporation.Wed 14:03
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52

Related events

Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.Aug 28

Coverage

Newest first; wire copies grouped

Jul 13Insider MonkeyDanaher (DHR) Teams Up to Advance Precision Medicine Diagnostics Danaher Corporation (NYSE:DHR) is one of the 13 Best Large Cap Stocks to Buy Right Now. On May 29, Danaher Corporation (NYSE:DHR) anno